Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Sposito

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Journal of Hepatology|September 11, 2013
Reply to: "Time is a crucial factor for the use of oncological treatment for post-transplantation recurrence of hepatocellular carcinoma"Carlo Sposito, Vincenzo Mazzaferro
Journal of Hepatology|November 13, 2013
Reply to: "Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue"Carlo Sposito, Vincenzo Mazzaferro
Hepatobiliary Surgery and Nutrition|January 18, 2019
The SIRveNIB and SARAH trials, radioembolization <i>vs</i>. sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the futureCarlo Sposito, Vincenzo Mazzaferro
Annals of Surgical Oncology|July 18, 2023
ASO Author Reflections: A Green Eye on Lymphadenectomy for Gastric CancerCarlo Sposito, Marianna Maspero, Vincenzo Mazzaferro
Digestive Diseases and Sciences|March 11, 2019
Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular CarcinomaCarlo Sposito, Alessandro Cucchetti, Vincenzo Mazzaferro
Gastroenterology|May 12, 2018
ReplyCarlo Sposito, Alessandro Cucchetti, Vincenzo Mazzaferro
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 28, 2017
Pro (With Caution): Extended oncologic indications in liver transplantationVincenzo Mazzaferro, Carlo Battiston, Carlo Sposito
Annals of Surgical Oncology|March 2, 2022
ASO Author Reflections: Less is more: Organ-Sparing Approach for the Surgical Treatment of Gastric AdenocarcinomaMarianna Maspero, Carlo Sposito, Vincenzo Mazzaferro
Journal of Hepatology|April 30, 2018
Reply to: "Validation of response to yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion"Carlo Sposito, Carlo Spreafico, Vincenzo Mazzaferro
Journal of Hepatology|February 3, 2023
Reply to: "Letter regarding 'Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node negative intrahepatic cholangiocarcinoma' "Carlo Sposito, Alessandro Cucchetti, Vincenzo Mazzaferro
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Journal of Hepatology|September 11, 2013
Reply to: "Time is a crucial factor for the use of oncological treatment for post-transplantation recurrence of hepatocellular carcinoma"Carlo Sposito, Vincenzo Mazzaferro
Journal of Hepatology|November 13, 2013
Reply to: "Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue"Carlo Sposito, Vincenzo Mazzaferro
Hepatobiliary Surgery and Nutrition|January 18, 2019
The SIRveNIB and SARAH trials, radioembolization <i>vs</i>. sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the futureCarlo Sposito, Vincenzo Mazzaferro
Annals of Surgical Oncology|July 18, 2023
ASO Author Reflections: A Green Eye on Lymphadenectomy for Gastric CancerCarlo Sposito, Marianna Maspero, Vincenzo Mazzaferro
Digestive Diseases and Sciences|March 11, 2019
Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular CarcinomaCarlo Sposito, Alessandro Cucchetti, Vincenzo Mazzaferro
Gastroenterology|May 12, 2018
ReplyCarlo Sposito, Alessandro Cucchetti, Vincenzo Mazzaferro
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 28, 2017
Pro (With Caution): Extended oncologic indications in liver transplantationVincenzo Mazzaferro, Carlo Battiston, Carlo Sposito
Annals of Surgical Oncology|March 2, 2022
ASO Author Reflections: Less is more: Organ-Sparing Approach for the Surgical Treatment of Gastric AdenocarcinomaMarianna Maspero, Carlo Sposito, Vincenzo Mazzaferro
Journal of Hepatology|April 30, 2018
Reply to: "Validation of response to yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion"Carlo Sposito, Carlo Spreafico, Vincenzo Mazzaferro
Journal of Hepatology|February 3, 2023
Reply to: "Letter regarding 'Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node negative intrahepatic cholangiocarcinoma' "Carlo Sposito, Alessandro Cucchetti, Vincenzo Mazzaferro
Pageof 9